February 2023 – Page 12

In January, Piper Sandler initiated research coverage of Karuna with an overweight rating, saying it’s “blazing a new trail in Schizophrenia” treatments. “We believe that KRTX’s KarXT is poised to...

Feb 11 2023

Uncategorized

Schizophrenia Drugs Are Finally Getting an Overhaul

by Clinical Editor

No Comments

Fiddling with dopamine levels became the cornerstone of schizophrenia treatment, laying the foundation for the dopamine hypothesis of schizophrenia—the theory that a dysregulated dopamine system …

Feb 11 2023

Uncategorized

62-year-old woman diagnosed with schizophrenia reported missing

by Clinical Editor

No Comments

Authorities Thursday sought the public’s help to find an at-risk 62-year-old woman diagnosed with schizophrenia and diabetes in need of medical attention last seen in an unincorporated area between …

Feb 11 2023

Uncategorized

No Benefit of Long-Acting Antipsychotics in Schizophrenia?

by Clinical Editor

No Comments

In patients with early-phase schizophrenia, long-acting injectable antipsychotics (LAIs) provide no benefit over oral antipsychotics (OAs) in preventing discontinuation of antipsychotic treatment, new …

Feb 11 2023

Uncategorized

With scope unknown, nursing homes brace for new schizophrenia audits

by Clinical Editor

No Comments

Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations …

Feb 10 2023

Uncategorized